MARKHAM, Ontario, Oct. 16, 2017 -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of October 2017, which is payable on November 15, 2017 to shareholders of record at the close of business on October 31, 2017. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
Extendicare has a Dividend Reinvestment Plan (the “DRIP”), which provides Canadian resident holders of Common Shares with the opportunity to increase their respective investments at a 3% discount to the volume weighted average trading price of the Common Shares on the TSX for the five trading days immediately preceding the dividend payment date. A copy of the DRIP package is available under the investors section of Extendicare’s website.
ABOUT EXTENDICARE
Extendicare is a leading provider of care and services for seniors throughout Canada. Through our network of 114 operated senior care and living centres (65 owned/49 managed), as well as our home health care operations, we are committed to delivering care throughout the health care continuum to meet the needs of a growing seniors’ population in Canada. Our qualified and highly trained workforce of 23,800 individuals is dedicated to helping people live better through a commitment to quality service and a passion for what we do.
Forward-looking Statements
Information provided by Extendicare from time to time, including this release, contains or may contain forward-looking statements concerning anticipated financial events, results, circumstances, economic performance or expectations with respect to Extendicare and its subsidiaries, including, without limitation, statements regarding its business operations, business strategy, and financial condition. Forward-looking statements can be identified because they generally contain the words “anticipate”, “believe”, “estimate”, “expect”, “intend”, “objective”, “plan”, “project”, “will” or other similar expressions or the negative thereof. Forward-looking statements reflect management’s beliefs and assumptions and are based on information currently available, and Extendicare assumes no obligation to update or revise any forward-looking statement, except as required by applicable securities laws. These statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of Extendicare to differ materially from those expressed or implied in the statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on Extendicare’s forward-looking statements. Further information can be found in the disclosure documents filed by Extendicare with the securities regulatory authorities, available at www.sedar.com and on Extendicare’s website at www.extendicare.com.
For further information, contact:
Jillian E. Fountain
Corporate Secretary
Phone: (905) 470-5534; Fax: (905) 470-4003
Email: [email protected]
www.extendicare.com


Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 



